Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
1.900
-0.080 (-4.04%)
At close: Aug 25, 2025, 4:00 PM
1.990
+0.090 (4.74%)
After-hours: Aug 25, 2025, 4:15 PM EDT
APVO's stock price has decreased by -99.35% in the past year and price targets may not have had time to catch up.
Aptevo Therapeutics Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$5,920.00
Upside
+311,478.95%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Roth MKM | Roth MKM | Strong Buy Maintains $11,100 → $5,920 | Strong Buy | Maintains | $11,100 → $5,920 | +311,478.95% | Sep 23, 2024 |
Piper Sandler | Piper Sandler | Buy Maintains $2,246,640 → $651,200 | Buy | Maintains | $2,246,640 → $651,200 | +34,273,584.21% | May 13, 2022 |
Roth Capital | Roth Capital | Strong Buy Maintains $2,083,840 → $1,628,000 | Strong Buy | Maintains | $2,083,840 → $1,628,000 | +85,684,110.53% | May 28, 2021 |
Piper Sandler | Piper Sandler | Buy Maintains $1,041,920 → $2,246,640 | Buy | Maintains | $1,041,920 → $2,246,640 | +118,244,110.53% | Nov 11, 2020 |
Roth Capital | Roth Capital | Strong Buy Initiates $5,470,080 | Strong Buy | Initiates | $5,470,080 | +287,898,847.37% | Apr 11, 2018 |
Piper Sandler | Piper Sandler | Buy Initiates $3,190,880 | Buy | Initiates | $3,190,880 | +167,940,952.63% | Sep 9, 2016 |